每(mei)經AI快訊，威爾(er)藥業（SH 603351，收(shou)盤(pan)價：24.5元(yuan)）12月(yue)14日(ri)(ri)(ri)晚間發布公(gong)(gong)(gong)(gong)告(gao)稱，截至本公(gong)(gong)(gong)(gong)告(gao)披露日(ri)(ri)(ri)，公(gong)(gong)(gong)(gong)司高(gao)(gao)管(guan)(guan)王福秋先生(sheng)(sheng)直(zhi)接持有(you)公(gong)(gong)(gong)(gong)司股(gu)(gu)票20萬股(gu)(gu)，約占公(gong)(gong)(gong)(gong)司總股(gu)(gu)本的(de)(de)0.1476%，公(gong)(gong)(gong)(gong)司高(gao)(gao)管(guan)(guan)鄒建國先生(sheng)(sheng)直(zhi)接持有(you)公(gong)(gong)(gong)(gong)司股(gu)(gu)票5萬股(gu)(gu)，約占公(gong)(gong)(gong)(gong)司總股(gu)(gu)本的(de)(de)0.0369%，前述高(gao)(gao)管(guan)(guan)股(gu)(gu)份(fen)均通過(guo)公(gong)(gong)(gong)(gong)司2021年限制性(xing)股(gu)(gu)票激勵計劃授予取得。王福秋先生(sheng)(sheng)擬自公(gong)(gong)(gong)(gong)告(gao)披露之日(ri)(ri)(ri)起(qi)十五個(ge)交易日(ri)(ri)(ri)后(hou)6個(ge)月(yue)內通過(guo)集(ji)中(zhong)(zhong)競價交易方式，合(he)計減持公(gong)(gong)(gong)(gong)司股(gu)(gu)份(fen)不超(chao)(chao)過(guo)5萬股(gu)(gu)，即(ji)不超(chao)(chao)過(guo)公(gong)(gong)(gong)(gong)司總股(gu)(gu)本的(de)(de)0.0369%，亦不超(chao)(chao)過(guo)其(qi)(qi)直(zhi)接持有(you)公(gong)(gong)(gong)(gong)司股(gu)(gu)份(fen)總數(shu)(shu)的(de)(de)25%；鄒建國先生(sheng)(sheng)擬自公(gong)(gong)(gong)(gong)告(gao)披露之日(ri)(ri)(ri)起(qi)十五個(ge)交易日(ri)(ri)(ri)后(hou)6個(ge)月(yue)內通過(guo)集(ji)中(zhong)(zhong)競價交易方式，合(he)計減持公(gong)(gong)(gong)(gong)司股(gu)(gu)份(fen)不超(chao)(chao)過(guo)約1.25萬股(gu)(gu)，即(ji)不超(chao)(chao)過(guo)公(gong)(gong)(gong)(gong)司總股(gu)(gu)本的(de)(de)0.0092%，亦不超(chao)(chao)過(guo)其(qi)(qi)直(zhi)接持有(you)公(gong)(gong)(gong)(gong)司股(gu)(gu)份(fen)總數(shu)(shu)的(de)(de)25%。

2021年(nian)1至12月份，威爾(er)藥業(ye)的營(ying)業(ye)收(shou)入構成為：合成潤滑(hua)基礎(chu)油(you)占(zhan)比(bi)70.72%，藥用輔料占(zhan)比(bi)25.49%，其他占(zhan)比(bi)2.81%。

威爾藥(yao)業(ye)的總經理、董事長均是吳仁榮，男，59歲，學歷背景為碩士。

截至發稿，威爾藥業(ye)市值為33億(yi)元(yuan)。

道達號(hao)（daoda1997）“個股趨(qu)勢”提醒(xing)：
1. 威爾藥業近30日內北向資金持股量未發生變化；
2. 近30日內無機構對威爾藥業進行調研；
3. 威爾藥業上次發布減持公告是2022年01月11日，第二個交易日上漲10.08%，威爾藥業近一年共發布2次減持類公告。
更多個股趨勢(shi)信息，請搜索微信公(gong)眾號“道達號”，回復“查詢”，領取免費查詢權(quan)限！

每(mei)經頭條（nbdtoutiao）——

(記者 王曉波)

免(mian)責聲明：本文內容與數據(ju)僅供參考，不構成投資建議(yi)，使(shi)用前請(qing)核(he)實。據(ju)此操作，風險自擔。